𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease

✍ Scribed by Goto, S.; Ogawa, H.; Takeuchi, M.; Flather, M. D.; Bhatt, D. L.


Book ID
126716237
Publisher
Oxford University Press
Year
2010
Tongue
English
Weight
448 KB
Volume
31
Category
Article
ISSN
0195-668X

No coin nor oath required. For personal study only.